Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease.
Recurrent ventricular tachycardia (VT) in the setting of coronary artery disease is frequently a life-threatening electrophysiologic emergency. Even in patients with an implantable defibrillator, recurrent VT is frequently accompanied by repeated and disabling shock therapy. Catheter ablative therapy offers the ability to provide immediate control of recurrent VT. Long-term elimination of VT should be anticipated in most patients. This article reviews the strategies, tools, techniques, and expected outcome for catheter ablation of stable and unstable ventricular arrhythmias in the setting ischemic heart disease.
Marchlinski
Francis
F
Electrophysiology Section, Division of Cardiology, University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA. francis.marchlinski@uphs.upenn.edu
Garcia
Fermin
F
Siadatan
Amir
A
Sauer
William
W
Beldner
Stuart
S
Zado
Erica
E
Hsia
Henry
H
Lin
David
D
Cooper
Joshua
J
Verdino
Ralph
R
Gerstenfeld
Edward
E
Dixit
Sanjay
S
Russo
Andrea
A
Callans
David
D
D017115:Catheter Ablation / Q000379:methods*; D006801:Humans; D017202:Myocardial Ischemia / Q000150:complications / Q000601:surgery*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D055502:Secondary Prevention; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control*